eznews.inThe Cancer Research Institute (CRI) has launched the CRI Discovery Engine, an innovative AI-ready database aimed at accelerating cancer immunotherapy research. In collaboration with leading institutions such as Stanford University and Memorial Sloan Kettering Cancer Center, this initiative addresses critical challenges in oncology, including limited data sharing and poor reproducibility of results. Initially focusing on melanoma and colorectal cancer, the platform will provide standardized, high-resolution data on immune responses to treatments, including both successful and failed interventions. By making this information openly accessible, the Discovery Engine aims to foster collaboration among researchers, breaking down silos that hinder progress. CRI's CEO, Alicia Zhou, emphasized the importance of collective efforts in overcoming barriers to treatment development. The initial dataset is expected to be available within a year, marking a potential turning point in understanding and improving immunotherapy outcomes. 
Published: Jan 22 2026, 12 ameznews.inA recent meta-analysis has dispelled concerns linking acetaminophen, commonly known as Tylenol, to autism and ADHD risks in children when used during pregnancy. Following a 2025 U.S. government warning about potential associations between prenatal acetaminophen use and neurodevelopmental disorders, this comprehensive review conducted by international researchers found no evidence to support such claims. The analysis focused on high-quality studies, including sibling comparison designs, which effectively controlled for genetic and environmental factors. Experts, including Dr. Anand Singh and Dr. Jagdish Khubchandani, emphasized the importance of treating fever during pregnancy, highlighting that untreated conditions pose risks to both mother and child. While some health officials continue to express caution regarding acetaminophen use, many clinicians agree that the findings should reassure expectant mothers about the safety of using the medication as directed. The review underscores the complexity of autism, attributing it to multifactorial causes, primarily genetic.
Published: Jan 21 2026, 11 pmeznews.inRecent changes to vaccine recommendations in the United States have sparked confusion among healthcare providers and the public, raising concerns about vaccine access and insurance coverage. The Advisory Committee on Immunization Practices (ACIP), which has guided vaccine policies since 1964, underwent a significant overhaul in June 2025, resulting in the withdrawal of several longstanding vaccine recommendations despite strong scientific backing. Notably, thimerosal-containing flu vaccines were removed from the schedule, and the combined measles, mumps, and rubella (MMR) vaccine is no longer recommended for children under three, with calls for separate shots lacking scientific justification. While federal officials assert that vaccines recommended as of December 2025 will continue to be covered by insurance, experts warn that these revisions may lead to increased costs and public distrust. Clinicians are encouraged to engage in discussions with families about the scientific basis for vaccinations, emphasizing their importance in preventing disease and maintaining public health.
Published: Jan 21 2026, 2 ameznews.inA recent study published in PNAS has shed light on how exercise can combat muscle loss associated with aging, revealing its effects at a molecular level. As muscle mass declines by 3-8% per decade from age 30, researchers found that exercise, particularly resistance training, inhibits a transcription factor known as DEAF1, which contributes to muscle deterioration. DEAF1 becomes more active with age, disrupting protein balance and impairing muscle repair. By activating protective genes called FOXO, exercise helps restore the muscle cell's ability to recycle damaged proteins and maintain strength. The study emphasizes that both aerobic and resistance exercises are beneficial, and even older adults can activate this protective pathway through increased physical activity. Researchers hope these findings will encourage more people to engage in regular exercise as a means to enhance mobility and independence in later life, and potentially inspire new treatments for healthy aging.
Published: Jan 20 2026, 3 pmeznews.inMount Sinai's Tisch Cancer Center has launched an innovative artificial intelligence (AI) platform named PRISM to enhance cancer patients' access to clinical trials. Despite the existence of thousands of cancer-related trials annually, only about 7% of patients participate due to various barriers, including lack of awareness and logistical challenges. The PRISM platform utilizes a specialized oncology language model to analyze electronic medical records, streamlining the identification of eligible patients for trials. Dr. Karyn Goodman, a key figure at the center, emphasized that this automated system reduces the manual workload for staff and improves access to cutting-edge treatments for diverse populations. Experts, including oncologist Dr. Nilesh Vora, support the initiative, noting that it could significantly increase enrollment in trials, thereby advancing cancer research and treatment. The platform aims to enhance equity and diversity in clinical trial participation while lowering recruitment costs.
Published: Jan 19 2026, 2 pmeznews.inA new study published in *The Lancet* suggests that small lifestyle changes, such as increasing daily physical activity by just five minutes or reducing sitting time by 30 minutes, could significantly enhance longevity. Researchers analyzed data from over 150,000 adults across the US, Sweden, Norway, and the UK, concluding that these modest adjustments could prevent up to 10% of deaths among the least active individuals. Specifically, the study found that an additional five minutes of moderate-to-vigorous activity could lower mortality rates by 6% in the least active 20% of participants, while sitting less could prevent approximately 7% of deaths across the broader population. Experts emphasize the profound health benefits of incorporating even minimal movement into daily routines, highlighting a growing societal shift towards lifestyle modifications over medication. The findings underscore the importance of physical activity in enhancing both lifespan and healthspan, with implications for public health strategies.
Published: Jan 19 2026, 6 pmeznews.inA recent study from Spain has found no significant link between the timing of menopause and the risk of developing type 2 diabetes. Researchers analyzed health data from 146,764 postmenopausal women over an average of 14.5 years, categorizing them based on menopause onset age. While earlier menopause appeared associated with higher diabetes rates, this association disappeared after adjusting for lifestyle and health factors, such as obesity and smoking. The study concluded that the timing of menopause—whether it occurs before age 40, between 40 and 45, or after 45—does not independently increase diabetes risk. Experts emphasize that maintaining a healthy lifestyle, including proper diet and physical activity, is crucial for managing diabetes risk during and after menopause. The findings, published in the journal *Menopause*, highlight the importance of empowering women to control modifiable risk factors for better health outcomes.
Published: Jan 18 2026, 2 pmeznews.inA recent study published in *The Lancet Healthy Longevity* has found no evidence that hormone replacement therapy (HRT) affects dementia risk in post-menopausal women. This research, which analyzed data from over 1 million participants across 10 studies, addresses ongoing debates regarding HRT's potential impact on cognitive health. Despite existing research indicating that women are disproportionately affected by dementia, the study's lead author, Melissa Melville, emphasized the need for clearer, evidence-based guidelines for HRT, particularly as the World Health Organization currently offers no advice on the matter. Experts, including Dr. Manisha Parulekar and Dr. G. Thomas Ruiz, cautioned that while the findings are significant, they do not definitively resolve the relationship between hormones and cognition, underscoring the necessity for more high-quality, long-term studies to better understand dementia prevention strategies.
Published: Jan 17 2026, 2 pmeznews.inOpenAI has launched ChatGPT Health, a feature designed to assist users with health and wellness inquiries, responding to the millions of health-related questions it receives daily. This tool aims to enhance patient preparedness for medical consultations by summarizing lab results and organizing questions. However, experts like Dr. David Liebovitz caution that while ChatGPT Health can facilitate discussions, it should not replace clinical judgment. Patients might mistakenly equate AI-generated information with professional advice, risking overconfidence in its accuracy. The tool lacks accountability and legal protections, meaning sensitive health conversations are not confidential. Liebovitz emphasizes that healthcare professionals must guide patients in using AI responsibly, focusing on preparation rather than diagnosis, verifying any critical information, and understanding privacy implications. As AI becomes integrated into healthcare, it is crucial that clinicians maintain trust and shared decision-making with patients, ensuring that technology enhances rather than diminishes the patient-provider relationship.
Published: Jan 16 2026, 10 pmeznews.inResearchers have developed a new tool aimed at identifying the risk of metastatic hormone-sensitive prostate cancer (mHSPC) at diagnosis, potentially guiding early treatment decisions. This innovative system predicts early responses in prostate-specific antigen (PSA) levels in patients prescribed androgen receptor pathway inhibitors (ARPI), which are increasingly used in prostate cancer treatment. The study, published in Nature Communications, utilized data from three clinical trials, training a multivariable logistic regression model on 1,030 participants and validating it with 688 others. The findings suggest that the tool can effectively identify high-risk patients who may respond poorly to standard therapies, allowing for personalized treatment plans. Experts emphasize the importance of such innovations in enhancing decision-making for prostate cancer management, particularly as the global prevalence of the disease continues to rise. Further validation of the tool in real-world settings is underway, with hopes for its integration into clinical practice and trials.
Published: Jan 16 2026, 6 pmFor the fastest, latest, not so wokest news, 'experts say' you need to visit Eznews
India
World
Economy
Science
Health
Showbiz
Contact